Phosphatidylinositol 3-kinase (PI3-kinase) activates protein kinase B (also
known as Akt), which phosphorylates and activates a cyclic nucleotide phos
phodiesterase 3B. Increases in cyclic nucleotide concentrations inhibit ago
nist-induced contraction of vascular smooth muscle. Thus we hypothesized th
at the PI3-kinase/Akt pathway may regulate vascular smooth muscle tone. In
unstimulated, intact bovine carotid artery smooth muscle, the basal phospho
rylation of Akt was higher than that in cultured smooth muscle cells. The p
hosphorylation of Akt decreases in a time-dependent manner when incubated w
ith the PI3-kinase inhibitor, LY-294002. Agonist (serotonin)-, phorbol este
r (phorbol 12,13-dibutyrate; PDBu)-, and depolarization (KCI)-induced contr
actions of vascular smooth muscles were all inhibited in a dose-dependent f
ashion by LY-294002. However, LY-294002 did not inhibit serotonin- or PDBu-
induced increases in myosin light chain phosphorylation or total O-2 consum
ption, suggesting that inhibition of contraction was not mediated by revers
al or inhibition of the pathways that lead to smooth muscle activation and
contraction. Treatment of vascular smooth muscle with LY-294002 increased t
he activity of cAMP-dependent protein kinase and increased the phosphorylat
ion of the cAMP-dependent protein kinase substrate heat shock protein 20 (H
SP20). These data suggest that activation of the PI3-kinase/Akt pathway in
unstimulated smooth muscle may modulate vascular smooth muscle tone (allow
agonist-induced contraction) through inhibition of the cyclic nucleotide/HS
P20 pathway and suggest that cyclic nucleotide-dependent inhibition of cont
raction is dissociated from the myosin light chain contractile regulatory p
athways.